| Issue |
Section |
Title |
File |
| Vol 8, No 8 (2022) |
Articles |
Therapy of asthenia in patients after acute novel coronavirus infection (COVID-19): results of a multicenter, randomized, double-blind, placebocontrolled clinical study |
|
| Vol 8, No 10 (2022) |
Articles |
Structure of polymorbidities of the digestive diseases in patients receiving direct oral anticoagulants: results of a multicenter cross-sectional pharmacoepidemiological study |
|
| Vol 7, No 7 (2021) |
Articles |
Drug-induced hyperuricemia/gout. Part 2: certain medicines, the use of which is associated with an increased risk of developing of these diseases |
|
| Vol 8, No 4 (2022) |
Articles |
DRUG SAFETY AND POLYMORBIDITY AS IMPORTANT COMPONENTS OF RATIONAL PHARMACOTHERAPY IN CARDIOLOGY |
|
| Vol 8, No 6 (2022) |
Articles |
The use of nadroparin in clinical practice |
|
| Vol 9, No 1 (2023) |
ACTUAL ISSUES OF PHARMACOTHERAPY AND PREVENTIVE TREATMENT |
International multicenter randomized double-blind placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol® and Mexidol® FORTE 250 in patients with chronic brain ischemia (memo): subanalysis in patients with arterial hypertension |
|
| Vol 9, No 2 (2023) |
ACTUAL ISSUES OF PHARMACOTHERAPY AND PREVENTIVE TREATMENT |
Insomnia as a comorbid disorder |
|
| Vol 9, No 8 (2023) |
ACTUAL ISSUES OF PHARMACOTHERAPY AND PREVENTIVE TREATMENT |
More on the neuroprotectory therapy evidential base: focus at ethylmethyl hydroxypyridine succinate |
|
| Vol 10, No 2 (2024) |
HELPING PRACTICING PHYSICIAN |
Approaches to diagnostics, differential diagnosis and treatment of anemia in therapeutic practice |
|
| Vol 10, No 5 (2024) |
ORIGINAL STUDIES |
Dependence of cognitive profile of multimorbid elderly patients with hypertension from charlson comorbidity index |
|
| Vol 10, No 7 (2024) |
LECTURES & REPORTS |
Pathogenesis of virus-induced inflammation: from theory to development and implementation of a new paradigm of medicinal remedies |
|
| Vol 10, No 9 (2024) |
CLINICAL CASE |
Difficulties of antianginal therapy selecting in an elderly polymorbid patient with coronary heart disease |
|
